Jeena Sikho

Zirakpur, India Founded: 2002 • Age: 24 yrs Listed
Ayurvedic remedies and wellness products are offered for healthcare needs.
Request Access
Report Incorrect Data
Page last updated

About Jeena Sikho

Jeena Sikho is a publicly listed company based in Zirakpur (India) founded in 2002 by Manish Grover. It operates as an ayurvedic remedies and wellness products are offered for healthcare needs. The company has 1,541 employees. Its chief executive is Manish Grover. Its website jeenasikho.com draws about 585 thousand monthly visits. Its Indian entity Jeena Sikho Lifecare Limited reported revenue of ₹475 Cr. Its focus areas include Clinic Chains and Ayurveda. Its competitors include Charak, Ayushakti Ayurveda, Shathayu Ayurveda, Dr Dassan and Keva Ayurveda and 1 more.

Company details

Jeena Sikho was founded in 2002 and is headquartered in Zirakpur, India. Operations are centered in the Ayurvedic healthcare sector, where traditional remedies and natural products are provided to address detoxification, digestion, and overall wellness. Services include supplements and beauty care solutions, with a focus on holistic health for individuals and families across India.

Operational Areas
Healthcare → Hospitals & Clinical Care
Key Metrics
  • Market Cap
    ₹4,596 Cr

    JSLL · NSE

  • Share Price
    ₹369.75

    -4.78% today

  • Revenue
    ₹801 Cr

    FY 2025-26

  • EBITDA
    ₹349 Cr

    Margin 43.6%

  • Net Profit
    ₹222 Cr

    FY 2025-26

  • P/E (TTM)
    20.4x

    P/B 10.3x

  • Employee Count
    1,541

Apps and channels of Jeena Sikho

its YouTube channel Jeena Sikho Lifecare Ltd has 24.8K subscribers and 30 videos.

Jeena Sikho Lifecare Ltd
YouTube 24.8K subscribers 30 videos Science & Technology
Open channel

Videos from Jeena Sikho

The most watched videos on Jeena Sikho's YouTube channel, Jeena Sikho Lifecare Ltd (24.8K subscribers). Click a video to play it here.

दाल को खाए इस तरीके से मिलेगा भरपूर न्यूट्रिशन | Healthy Life with Acharya Manish Ji
29.3K views
Happy Patient Feedback | Anxiety Disorder | Back Pain | Stress | Shuddhi Ayurveda
3.8K views
आयुर्वेद पंचकर्म में कैशलेस इलाज सुविधा उपलब्ध है आज ही संपर्क करें 9311300967
3.1K views
RGHS Patient Review | RA Factor | Ayurveda | Panchkarma | Shuddhi Ayurveda
2.7K views

More on Jeena Sikho Lifecare Ltd.

Board of directors of Jeena Sikho Lifecare Limited (Jeena Sikho)

Jeena Sikho Lifecare Limited is the primary company behind Jeena Sikho. The board of Jeena Sikho Lifecare Limited currently have 10 directors; the longest-serving is Shreya Grover, appointed in 2021. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Shreya Grover
DIN 09199495
Whole-time director12 Jun 20215 yrs 4 moJeena Sikho Lifecare Limited
Karan Vir Bindra
DIN 09283623
Director25 Aug 20215 yrs 1 moJeena Sikho Lifecare Limited
Manish Grover
DIN 07557886
Managing Director25 Aug 20215 yrs 1 moJeena Sikho Lifecare Limited
Bhavna Grover
DIN 07557913
Whole-time director25 Aug 20215 yrs 1 moJeena Sikho Lifecare Limited
Chandan Kumar Kaushal
DIN 10515819
Director29 Apr 20242 yrs 5 moJeena Sikho Lifecare Limited
Priyanka Bansal
DIN 09051665
Director21 Apr 20251 yr 5 moJeena Sikho Lifecare Limited
Ankush Kaushal
DIN 03308862
Whole-time director15 Jul 20263 moJeena Sikho Lifecare Limited
Ajay Sharma
DIN 07671350
Director15 Jul 20263 moJeena Sikho Lifecare Limited
Sapna Singh
DIN 11812894
Director15 Jul 20263 moJeena Sikho Lifecare Limited
Ish Sharma
DIN 11815526
Whole-time director15 Jul 20263 moJeena Sikho Lifecare Limited

People of Jeena Sikho

1 people are tracked at Jeena Sikho (1 in leadership); the tracked headcount is 1,541.

NameRoleGroup
Manish Grover
Founder & Owner & CEOLeadership
Premium access

Complete people profiles for Jeena Sikho

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Jeena Sikho

Jeena Sikho is a publicly listed company on the NSE with ticker symbol JSLL in India, operating in the Pharmaceuticals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: JSLL
  • Listed entityJeena Sikho Lifecare Limited
  • Exchange sectorPharmaceuticals

Financials of Jeena Sikho

Exchange-reported figures of Jeena Sikho Lifecare Limited, the listed company behind Jeena Sikho (NSE: JSLL).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹801 Cr
+291.4% YoY
EBITDA
₹349 Cr
+662.1% YoY
Profit After Tax
₹222 Cr
+564.5% YoY
Net Worth
₹467 Cr
+271.3% YoY
Total Assets
₹601 Cr
+374.2% YoY
Total Debt
₹127 Cr
- YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2022-23FY 2021-22
Income statement
Revenue801205147
Revenue growth-+39.7%-
EBITDA34945.8518.09
EBITDA margin+43.6%+22.4%+12.3%
Profit before tax29744.3015.09
Net profit22233.3910.65
Net profit margin+27.7%+16.3%+7.3%
EPS (₹)17.8124.4611.11
Balance sheet
Total assets60112744.00
Net worth46712636.51
Total debt1270.817.43
Cash & bank10932.392.59
Net working capital17248.594.26
Cash flow
Cash from operations25414.5216.35
Cash from investing(202)(33.10)(18.49)
Cash from financing(58.68)48.00(4.51)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue224216222190174139116114
Revenue growth (YoY)+28.8%+54.8%+91.6%+66.4%+74.2%---
Other income14.333.422.571.441.070.270.393.45
EBITDA92.0677.9210192.0378.7645.7729.6140.27
EBITDA margin+41.0%+36.1%+45.4%+48.5%+45.2%+32.9%+25.6%+35.3%
Depreciation15.3916.3811.2610.409.659.038.476.25
Interest3.473.733.104.351.663.103.792.07
Profit before tax87.5361.2388.9378.7268.5233.9117.7435.40
Tax21.6416.1422.3319.9717.248.584.538.81
Net profit65.8945.0966.6058.7551.2825.3313.2126.59
EPS (₹)5.293.625.354.724.122.041.062.14
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue80146932420414613694.42
Revenue growth+70.8%+44.6%+59.1%+39.2%+7.8%+43.8%-
EBITDA35012593.0146.3218.1616.9610.55
EBITDA margin+43.6%+26.7%+28.7%+22.7%+12.4%+12.5%+11.2%
Profit before tax29812293.9244.5215.1614.217.73
Net profit22288.2567.8733.3410.6810.425.74
Net profit margin+27.7%+18.8%+20.9%+16.4%+7.3%+7.7%+6.1%
EPS (₹)17.8536.5027.8424.4311.151,015.21572.63
Balance sheet
Total assets60137719312744.0736.4626.41
Net worth46725619212636.5523.9513.73
Total debt1271170.540.817.4312.0312.46
Cash & bank10822.9862.0132.392.578.961.44
Net working capital16390.0911448.594.8313.709.46
Cash flow
Cash from operations26284.5036.6917.1717.4817.5311.74
Cash from investing(211)(64.38)(18.05)(57.23)(19.64)(8.47)(5.97)
Cash from financing(58.73)(22.45)(3.44)48.00(4.51)(1.53)(5.05)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue224216222190174139116114
Revenue growth (YoY)+28.8%+54.8%+91.6%+66.4%+74.2%---
Other income14.023.582.571.441.070.270.393.45
Total expenses13213812197.7895.5093.4886.0873.82
EBITDA92.1277.9810192.0778.7945.7729.6140.27
EBITDA margin+41.1%+36.2%+45.5%+48.5%+45.2%+32.9%+25.6%+35.3%
Depreciation15.3316.3211.2110.409.659.038.476.25
Interest3.473.733.104.351.663.103.792.07
Profit before tax87.3461.5189.0578.7668.5533.9117.7435.40
Tax21.6516.1522.3319.9717.248.584.538.81

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 20 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue224216222190174139116114
Revenue growth (YoY)+28.8%+54.8%+91.6%+66.4%+74.2%---
Other income14.333.422.571.441.070.270.393.45
EBITDA92.0677.9210192.0378.7645.7729.6140.27
EBITDA margin+41.0%+36.1%+45.4%+48.5%+45.2%+32.9%+25.6%+35.3%
Depreciation15.3916.3811.2610.409.659.038.476.25
Interest3.473.733.104.351.663.103.792.07
Profit before tax87.5361.2388.9378.7268.5233.9117.7435.40
Tax21.6416.1422.3319.9717.248.584.538.81
Net profit65.8945.0966.6058.7551.2825.3313.2126.59
EPS (₹)5.293.625.354.724.122.041.062.14
ParticularsFY 2025-26FY 2022-23FY 2021-22
Revenue801205147
Revenue growth-+39.7%-
Other income8.502.601.49
Total expenses452159128
Employee cost0.0044.0533.80
EBITDA34945.8518.09
EBITDA margin+43.6%+22.4%+12.3%
Depreciation47.693.203.31
Interest12.830.951.18
Profit before tax29744.3015.09
Tax75.6910.773.89
Net profit22233.3910.65
Net profit margin+27.7%+16.3%+7.3%
EPS (₹)17.8124.4611.11
ParticularsFY 2025-26FY 2022-23FY 2021-22
Equity & liabilities
Share capital24.8613.8110.11
Reserves & surplus44211226.40
Shareholders' funds (net worth)46712636.51
Minority interest(0.13)0.00(0.03)
Secured loans0.430.811.08
Unsecured loans1270.006.35
Total debt1270.817.43
Total liabilities60112744.00
Assets
Gross block38470.7636.84
Net block29359.7428.59
Capital work in progress2.861.135.04
Investments1104.550.00
Inventories20.224.106.36
Sundry debtors69.9322.079.04
Cash & bank balances10932.392.59
Loans & advances46.7814.363.53
Total current assets24672.9221.52
Total current liabilities73.4324.3317.26
Net working capital17248.594.26
Total assets60112744.00
ParticularsFY 2025-26FY 2022-23FY 2021-22
Opening cash22.982.198.84
Net cash from operating activities25414.5216.35
Net cash from investing activities(202)(33.10)(18.49)
Net cash from financing activities(58.68)48.00(4.51)
Net change in cash(6.61)29.42(6.65)
Closing cash10932.392.59
ParticularsFY 2025-26FY 2022-23FY 2021-22
Growth
Sales growth-+39.7%-
EBITDA growth-+153.5%-
PBT growth+571.3%+193.6%+9997.0%
Net income growth-+213.5%-
Profitability & leverage
Net income margin+27.7%+16.4%+7.6%
Return on capital employed-+53.0%+37.0%
Return on net worth-+41.3%+30.7%
Debt / equity-0.050.20
Long-term debt / equity-0.010.02
Interest cover4.252.237.98
Efficiency & per share
Fixed asset turnover-3.813.98
Inventory turnover-39.1523.04
Debtors turnover-13.1616.21
EPS (₹)17.8124.4611.11
Dividend per share (₹)4.502.000.00
Book value per share (₹)0.0091.0936.11
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue224216222190174139116114
Revenue growth (YoY)+28.8%+54.8%+91.6%+66.4%+74.2%---
Other income14.023.582.571.441.070.270.393.45
Total expenses13213812197.7895.5093.4886.0873.82
EBITDA92.1277.9810192.0778.7945.7729.6140.27
EBITDA margin+41.1%+36.2%+45.5%+48.5%+45.2%+32.9%+25.6%+35.3%
Depreciation15.3316.3211.2110.409.659.038.476.25
Interest3.473.733.104.351.663.103.792.07
Profit before tax87.3461.5189.0578.7668.5533.9117.7435.40
Tax21.6516.1522.3319.9717.248.584.538.81
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue80146932420414613694.42
Revenue growth+70.8%+44.6%+59.1%+39.2%+7.8%+43.8%-
Other income8.666.416.442.281.491.070.76
Total expenses45234423115812811983.87
Employee cost0.0010065.9143.4433.7530.3821.65
EBITDA35012593.0146.3218.1616.9610.55
EBITDA margin+43.6%+26.7%+28.7%+22.7%+12.4%+12.5%+11.2%
Depreciation47.588.715.103.133.312.461.94
Interest12.830.970.430.951.181.361.64
Profit before tax29812293.9244.5215.1614.217.73
Tax75.7031.3424.7110.783.893.891.99
Net profit22288.2567.8733.3410.6810.425.74
Net profit margin+27.7%+18.8%+20.9%+16.4%+7.3%+7.7%+6.1%
EPS (₹)17.8536.5027.8424.4311.151,015.21572.63
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital24.8624.8624.8613.8110.110.100.10
Reserves & surplus44323116711226.4423.8513.63
Shareholders' funds (net worth)46725619212636.5523.9513.73
Secured loans0.430.740.540.811.080.230.66
Unsecured loans1271160.000.006.3511.8011.80
Total debt1271170.540.817.4312.0312.46
Total liabilities60137719312744.0736.4626.41
Assets
Gross block38329882.3870.7636.5928.3319.98
Net block29225366.8559.7428.3422.6816.66
Capital work in progress2.7113.483.941.135.040.000.00
Investments1103.564.144.550.010.000.00
Inventories20.1711.557.194.105.769.2810.56
Sundry debtors69.9384.9641.1922.078.973.244.38
Cash & bank balances10822.9862.0132.392.578.961.44
Loans & advances37.5012.5830.4614.364.744.614.54
Total current assets23513214172.9222.0426.0920.92
Total current liabilities71.8941.9827.1924.3317.2112.3911.46
Net working capital16390.0911448.594.8313.709.46
Total assets60137719312744.0736.4626.41
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash22.9825.3110.122.178.841.440.71
Net cash from operating activities26284.5036.6917.1717.4817.5311.74
Net cash from investing activities(211)(64.38)(18.05)(57.23)(19.64)(8.47)(5.97)
Net cash from financing activities(58.73)(22.45)(3.44)48.00(4.51)(1.53)(5.05)
Net change in cash(7.82)(2.34)15.207.94(6.67)7.530.73
Closing cash10822.9862.0132.392.578.961.44
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+70.8%+44.6%+59.1%+39.2%+7.8%+43.8%-
EBITDA growth+179.0%+34.8%+100.8%+155.1%+7.1%+60.8%-
PBT growth+144.0%+30.0%+111.0%+193.7%+6.7%+83.8%-7.1%
Net income growth+151.8%+30.0%+103.6%+212.2%+2.5%+81.5%-
Revenue CAGR (3Y)+57.8%+47.4%+33.7%+29.3%+11.4%--
EBITDA CAGR (3Y)+96.2%+90.4%+76.4%+63.8%+19.6%--
Profitability & leverage
Net income margin+27.7%+19.3%+21.3%+16.6%+7.7%+7.6%+6.1%
Return on capital employed-+51.3%+59.0%+53.3%+40.6%+49.4%+37.4%
Return on net worth-+39.0%+43.5%+41.6%+37.3%+54.6%+52.7%
Debt / equity-0.020.000.050.320.651.29
Long-term debt / equity-0.000.000.010.020.020.05
Interest cover4.250.830.492.207.959.3819.05
Efficiency & per share
Fixed asset turnover-3.624.243.804.515.625.55
Inventory turnover-50.0657.4741.3619.4713.698.13
Debtors turnover-6.7610.2613.1423.9935.6522.01
EPS (₹)17.8536.5027.8424.4311.151,015.21572.63
Dividend per share (₹)4.505.474.802.000.000.000.00
Book value per share (₹)0.00109.8277.3391.0936.152,362.311,372.83

Competitors of Jeena Sikho

Jeena Sikho has 6 listed competitors in our database. They include Charak, Ayushakti Ayurveda, Shathayu Ayurveda, Dr Dassan and Keva Ayurveda, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Charak
charak.com1947Mumbai, India–288
Ayurvedic medicines and herbal healthcare products are provided.
Ayushakti Ayurveda
ayushakti.com1987Mumbai, India––
Chain of complementary and alternative therapy centers
Shathayu Ayurveda
shathayu.com1901Bengaluru, India–38
Chain of complementary and alternative therapy centers
Dr Dassan
drdassans.com2013Delhi, India––
Chain of complementary and alternative therapy centers
Keva Ayurveda
kevaayurveda.com2011Bengaluru, India–1
Operates a chain of centers offering complementary and alternative therapy services.
Adara Ayurveda
adaraayurveda.com1884Bengaluru, India––
Chain of complementary and alternative therapy centers
Premium access

Detailed competitors of Jeena Sikho

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Jeena Sikho

The website of Jeena Sikho (jeenasikho.com) receives about 585.4K visits a month and ranks #105,677 among all websites worldwide, #6,660 in Investing.

  • Monthly visits
    585.4K

    ▲ 37.5% vs previous month

  • Unique visitors
    218.2K

    per month

  • Global rank
    #105,677

    among all websites

  • Category rank
    #6,660

    Finance · Investing

Similar websites

Websites whose visitors overlap most with Jeena Sikho. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
vaidban.com
vaidban.com
100%
–#133,565–
screener.in
screener.in
86%
–#1,968–
refreshyourlife.in
refreshyourlife.in
75%
–#1,018,641–
sheopals.com
sheopals.com
75%
–#1,194,639–
Supertails
supertails.com
75%
1.4M#47,713View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 20 similar websites and full traffic analytics for Jeena Sikho

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 20 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

10 companies that operate in the same segment as Jeena Sikho (Hospitals & Clinical Care), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cloudnine
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
HCG
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 36.59 MUSD 270.51 M8,400
Medanta
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
KIMS Hospitals
Multispeciality secondary and tertiary care is provided by hospital chains.
1999Secunderabad, Telangana, IndiaUSD 62.46 MUSD 416.2 M6,490
Max Healthcare
Multispecialty hospitals are operated as a chain in India.
2001Delhi, Delhi, India–USD 889.96 M26,830
HCA Healthcare
Multi-specialty hospitals and surgery centers are operated nationwide.
1968Nashville, Tennessee, United StatesUSD 97.27 MUSD 75.6 B316,000
Small Door
Standalone veterinary clinics are operated for pet care services.
2017New York, New York, United StatesUSD 98.5 M––
Ochsner
Healthcare services, research, education, and community support are provided.
1942United States–––
Cityblock
Provider of tech-heavy clinics for multiple healthcare solutions for patients
2017Brooklyn, New York, United StatesUSD 1.02 B–785
Manipal Hospitals
Multispecialty hospitals are operated as a chain in India.
1991Bengaluru, Karnataka, IndiaUSD 645.32 MUSD 1.1 B–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jeena Sikho

Jeena Sikho Lifecare: Launches Eight New Ayurvedic and Nutraceutical Products, Featuring Pain Relief and Plant Protein Options.
Exchange Update • 15 days ago
Jeena Sikho Lifecare: To Hold Analyst And Investor Meeting On September 29 At 11 AM
Exchange Update • 28 days ago
Ashapura Minechem Ltd leads losers in 'A' group | Capital Market News - Business Standard
Business Standard • 2 months ago
Jeena Sikho Lifecare June-Quarter Consol Net Profit 659.5 Million Rupees
Reuters • 2 months ago
Stocks to watch: Reliance, HCL Tech, Sona BLW, HFCL, Mahindra Lifespace, Vedanta Oil, Saatvik Green, Rubicon Research - The HinduBusinessLine
Thehindubusinessline • 2 months ago
Jeena Sikho Lifecare To Establish New Hospital Facility With Over 160 Bed Capacity In Lucknow
Reuters • 4 months ago
Jeena Sikho Lifecare Commences Operations Of New Hospital In Mathura
Reuters • 4 months ago
Jeena Sikho Lifecare Says Co Received NABH Certificate Of Accreditation For Hospital Located In Bhopal
Reuters • 4 months ago
This Smallcap Is Up 100% in a Year but No One is Talking About it - Stock Insights News | The Financial Express
Financial Express • 6 months ago
Jeena Sikho Lifecare To Establish New Hospital Unit At 15 Million Rupees Investment
Reuters • 8 months ago
Premium access

Complete news archive for Jeena Sikho

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jeena Sikho

Jeena Sikho was founded in 2002.

Jeena Sikho is headquartered in Zirakpur, India. It is registered at Zirakpur, Punjab, India.

Manish Grover is the current CEO of Jeena Sikho. They have also founded this company.

Jeena Sikho has 1,541 employees.

The primary company behind Jeena Sikho, Jeena Sikho Lifecare Limited, reported revenue of ₹475 Cr for FY 2025, up 44% year on year.

Jeena Sikho was founded in 2002 and is headquartered in Zirakpur, India. Operations are centered in the Ayurvedic healthcare sector, where traditional remedies and natural products are provided to address detoxification, digestion, and overall wellness. Services include supplements and beauty care solutions, with a focus on holistic health for individuals and families across India.

Jeena Sikho's top competitors include Charak, Ayushakti Ayurveda and Shathayu Ayurveda.

Yes, Jeena Sikho is publicly traded on NSE under the ticker symbol JSLL.

Jeena Sikho operates through Jeena Sikho Lifecare Limited.

The legal entities of Jeena Sikho currently have 12 directors, including Karan Vir Bindra, Manish Grover, Shreya Grover and others.

The website of Jeena Sikho receives about 585 thousand visits a month and ranks #105,677 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available